W J van der Vijgh

Maastricht University Medical Centre — Netherlands

Medicine · Health Sciences

18h-index1.8kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(10), Vitamin D Research Studies(6), Chemotherapy-induced cardiotoxicity and mitigation(6), Pharmacological Effects and Toxicity Studies(3), Electron Spin Resonance Studies(3)

Publications25 total

Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profile
The FASEB Journal·2012
Differences in Pharmacological Activities of the Antioxidant Flavonoid MonoHER in Humans and Mice Are Caused by Variations in Its Metabolic Profile
Clinical Pharmacology & Therapeutics·2011· 13 cited
A phase I study of monohydroxyethylrutoside in healthy volunteers
Cancer Chemotherapy and Pharmacology·2005· 29 cited
Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: a need for guidelines.
PubMed·2000· 29 cited
Preclinical screening of the applicability of strontium as a marker for intestinal calcium absorption
American Journal of Physiology-Endocrinology and Metabolism·1997· 17 cited
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
Journal of Clinical Oncology·1997· 181 cited
Intestinal strontium absorption: from bioavailability to validation of a simple test representative for intestinal calcium absorption
Clinical Chemistry·1995· 23 cited
Sensitive method for analysis of strontium in human and animal plasma by graphite furnace atomic absorption spectrophotometry
Clinical Chemistry·1995· 17 cited
Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.
The Journal of Clinical Endocrinology & Metabolism·1995· 450 cited
One-hour test for estimating intestinal absorption of calcium by using stable strontium as a marker
Clinical Chemistry·1994· 31 cited
Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity.
PubMed·1993· 80 cited
Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial.
Journal of Clinical Oncology·1992· 32 cited
Limited sampling models for doxorubicin pharmacokinetics.
Journal of Clinical Oncology·1991· 41 cited
Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species.
PubMed·1990· 18 cited
Quantification of strontium in plasma and urine with flameless atomic absorption spectrometry.
Clinical Chemistry·1989· 28 cited
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.
Journal of Clinical Oncology·1988· 194 cited
Determinants of vitamin D status in patients with hip fracture and in elderly control subjects
American Journal of Clinical Nutrition·1987· 231 cited
Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
PubMed·1987· 94 cited
Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.
Clinical Chemistry·1986· 79 citedOpen Access
An international comparison of vitamin D metabolite measurements.
Clinical Chemistry·1984· 73 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

J. C. Netelenbos(9), Paul Lips(6), M. Jongen(4), Herbert M. Pinedo(4), Adriënne J.A.M. Sips(4), Rob Barto(4), Aalt Bast(4), F C van Ginkel(2), I. Klein(2), F. Elferink(2), J. B. Vermorken(2), Hanny Willems(2), Jan de Jong(2), H. M. Pinedo(2), H. Kurt Jacobs(2), Ger H. Koek(2), Ron Peters(2), Mohamed Moalin(2), Jan Tack(2), Guido R.M.M. Haenen(2)